Alloy review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Alloy starts compounded semaglutide at $70 for a one-month supply. The doctor is a separate $99 a month, and unusually, the same page tells you so.
The medication price is the smaller of the two numbers you pay. The program fee is charged separately every month, and although Alloy prints it on the same page directly under the medication, it never adds the two together for you.
- Advertised $70, actually $99
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
A menopause practice that prices the drug and the doctor as two adjacent lines instead of one misleading one — and publishes the clearest state exclusion list in this lane. Both medication figures are still floors.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded semaglutide, one-month supply
- From $70
- Compounded tirzepatide, one-month supply
- From $100
- Alloy Weight Care fee
- $99 a month, charged separately
- Where the fee is disclosed
- On the product page, under the price
- States excluded
- AL, AR, CA, NV, LA, MS and DC
- Legal entity
- Alloy Health, Inc.
- Pharmacy
- Not named on any page read
- Dose ladder
- Not published; both prices are floors
Pros and cons
What we like
- Prints the program fee on the product page, directly beneath the medication price.
- Says what the fee buys, item by item, rather than calling it access.
- Publishes a genuine state exclusion list on the product page, not buried in the terms.
- Sells the medication as a stated one-month supply rather than an open-ended plan.
- Names the legal entity and a postal address in its own terms of use.
- Carries a named prescribing physician as the medical reviewer on the semaglutide page.
What could be better
- No page adds the medication price and the program fee into one monthly figure.
- Both medication prices are "Starting at" floors with no dose bands published.
- No compounding pharmacy is named anywhere we read.
- The headline figure a shopper will compare against rivals is the smaller half of the real bill.
What it is
Alloy is a telehealth practice built around menopause, and its weight program is an extension of that rather than a separate business. Compounded semaglutide and compounded tirzepatide are each sold on their own product page, prescribed by physicians the site describes as menopause-trained, with dosing it says can be started lower and raised more gradually than a standard schedule. Its terms of use name Alloy Health, Inc. and give a New York postal address.
The framing is consistent enough to be worth noting as a fact about the product rather than as marketing: the pages argue that midlife weight change is hormonal and that a generic weight-loss program is the wrong tool for it. Whether or not a reader buys that argument, it explains why the clinician is priced as a standing relationship rather than as a one-off consultation.
Every price we found at Alloy
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, one-month supplyThe $70 is a starting price for the medication alone; the $99 is the separate monthly program fee charged alongside it. | $70 | $99 | September 2026 | |
| Compounded tirzepatide, one-month supplySame structure: a starting price for a one-month supply of the medication, with the $99 monthly program fee billed separately. | $100 | $99 | September 2026 | |
| Alloy Weight Care program feeMonthly. Covers unlimited messaging with the doctor, wellness check-ins, side-effect management, dose adjustments and long-term planning. Not a medication price. | not published | $99 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs at Alloy
Two numbers, not one. Compounded semaglutide starts at $70 for a one-month supply and compounded tirzepatide at $100 — and the Alloy Weight Care program is $99 a month on top of either.
What earns Alloy credit here is placement. The program fee is not in a footnote, a terms page or a checkout screen; it is printed on the product page directly beneath the medication price, with what it buys spelled out — unlimited messaging with the doctor, wellness check-ins, side-effect management, dose adjustments and long-term planning. A reader who looks at the price at all will see the fee in the same glance. That is more than most of this category manages, and it is the difference between a two-part price and a hidden one — we have read what a telehealth membership actually buys across the roster, and most sellers are far vaguer than this.
What it does not do is add them up. The honest monthly answer at Alloy is the medication plus ninety-nine dollars, and no page performs that sum or presents a combined figure. A shopper comparing the seventy-dollar headline against another seller's all-in rate is comparing two different things, and nothing on the page stops them.
Both medication figures are also written as "Starting at", with no dose bands, no plan lengths and no ceiling published anywhere we read. Titration is the single most common reason a GLP-1 bill rises in month four, and a practice that markets gentler, more gradual dose escalation is precisely the one where a reader would want to see what the later rungs cost.
It publishes a real state exclusion list, on the product page rather than buried in the terms: not available in AL, AR, CA, NV, LA, MS and DC.
Who it's wrong for
- Anyone in Alabama, Arkansas, California, Nevada, Louisiana, Mississippi or the District of Columbia. The product page says it is not available there.
- Anyone who wants a single all-in monthly number. Here it is always the medication plus the program fee, and you do the addition.
- Anyone who expects the starting price to be the price. Both medication figures are floors with no ladder published behind them.
- Anyone who needs to know which pharmacy compounds their medication. No page we read names one.
Medications available
- Compounded semaglutide injectionCompoundedFrom $70 for a one-month supply
Weekly self-injection. The program fee is charged separately.
- Compounded tirzepatide injectionCompoundedFrom $100 for a one-month supply
Weekly self-injection, dual GLP-1 and GIP action, again before the program fee.
Is Alloy legit?
Alloy is operated by Alloy Health, Inc., 99 Wall Street #2031, New York, NY 10005. We read that off the company’s own terms of use on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityAlloy Health, Inc.
- Postal addressPublished in the terms of use
- Pharmacy namedNot disclosed
- Drug formCompounded; not FDA-approved
- Who prescribesPhysicians the site describes as menopause-trained; one is named as the medical reviewer
- States excludedAL, AR, CA, NV, LA, MS and DC, stated on the product page
Common questions
How much does Alloy cost a month for a GLP-1?
The medication starts at $70 a month for compounded semaglutide or $100 for compounded tirzepatide, and the Alloy Weight Care program is a further $99 every month. Both figures are on the same product page, but the site never adds them together.
What does the Alloy Weight Care fee include?
The product page lists it: unlimited messaging with a menopause-specialized doctor, wellness check-ins, side-effect management, dose adjustments and long-term planning. It does not include the medication, which is priced separately on the same page.
Which states does Alloy not serve?
Its product pages say the GLP-1s are not available in Alabama, Arkansas, California, Nevada, Louisiana, Mississippi or the District of Columbia. That is an exclusion list rather than a coverage list, so it says nothing definite about the remaining states.
Does the Alloy price go up at a higher dose?
The site does not say. Both medication prices are written as starting prices, and no page we read publishes dose bands, a plan ladder or an upper figure, which matters more here because the practice markets gradual dose escalation.
Who is behind Alloy?
Its terms of use name Alloy Health, Inc. and give a postal address on Wall Street in New York. The semaglutide product page also carries a named prescribing physician as its medical reviewer, which is more prescriber disclosure than most sellers offer.
Why we gave Alloy a B
Read the full grading rationale
Alloy is built for one reader — women in midlife — and it prices like a company that expects to be checked. Each GLP-1 has its own product page, each page says what you are buying in words a shopper can act on ("1-month supply", "Weekly Injection"), and the program fee is printed directly under the medication price rather than three clicks away: $99 a month covering unlimited messaging with a menopause-specialized doctor, check-ins, side-effect management and dose adjustments. Compounded semaglutide starts at $70 and compounded tirzepatide at $100 for that one-month supply. It also publishes the single most useful state disclosure in this lane, and one of the few anywhere on the roster: not a count, not a badge, but an exclusion list — "Not available in AL, AR, CA, NV, LA, MS & DC" — and it prints it on the product page rather than burying it in the terms. Its terms name Alloy Health, Inc. and a New York postal address, and the semaglutide page carries a named prescribing physician as its medical reviewer. Two things hold it short of an A. Both medication figures are "Starting at" floors with no ladder behind them and no dose bands published, so a reader cannot see what a higher dose costs. And no page adds the two lines together: the honest monthly answer here is $70 plus $99, and the reader has to do that sum themselves.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed Alloy
- We read both GLP-1 product pages, the weight landing page and the terms of use in full on 2026-09-12, and took each figure from the product page that prints it.
- A nonsense path on the same host in the same session returned a discriminating HTTP 404, so a 200 on this host carries information.
- The state exclusion list is recorded as an exclusion and nothing is derived from it. We do not turn seven excluded jurisdictions into a claim about the other forty-four, because Alloy never made that claim.
- The FDA warning-letter screen ran on the company's own domain and the New York address in its terms, with a known-positive and a known-negative control passing in the same run. It returned no candidate letters, so the address half of the match was never exercised.
The 2 pages we read — all on
- Compounded semaglutide page
Compounded Semaglutide Starting at $70.00 1-month supply Weekly Injection Alloy Weight Care
- Compounded tirzepatide page
Compounded Tirzepatide Starting at $100.00 1-month supply Weekly Injection Alloy Weight Care
This link pays us nothing. It's here because the price is checkable.
Alternatives to Alloy
| Provider | Grade | Cheapest price |
|---|---|---|
| MyFastRx | BMinor gap | $69/mo |
| The Edit | BMinor gap | $69/mo |
| TOM Weight Loss | BMinor gap | $67/mo |
| OrderlyMeds | CCaveat | $74/mo |
| WeightWatchers Clinic | CCaveat | $74/mo |